Tauopathy Biochemistry

Tauopathies are neurodegenerative disorders that are caused due to the accumulation of abnormal tau proteins in neurons and/or the glia. Here is the latest research on tauopathy biochemistry.

September 23, 2020
Review

Tubulin modifying enzymes as target for the treatment of tau-related diseases

Pharmacology & Therapeutics
Krzysztof RogowskiSiem Van Der Laan
October 15, 2020
Preprint
Open Access

Tau protein in smooth muscle cells and tissues

BioRxiv : the Preprint Server for Biology
N. V. ShultsYuichiro J. Suzuki
October 14, 2020
Preprint
Open Access

Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathy

BioRxiv : the Preprint Server for Biology
E. LuengoManuela G Lopez
September 17, 2020
Preprint
Open Access

Modulation of Actin Network and Tau Phosphorylation by HDAC6 ZnF UBP Domain

ResearchSquare
Balmik Ankur BalmikSubashchandrabose Chinnathambi
October 5, 2020
Preprint
Open Access

EGCG modulates nuclear formaldehyde-induced Tau phosphorylation in Neuronal cells

BioRxiv : the Preprint Server for Biology
S. K. SonawaneSubashchandrabose Chinnathambi
September 23, 2020
Open Access

Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R

Neurobiology of Disease
Alexander SandbergKin Y Mok
September 25, 2020
Review
Open Access

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology

Cells
Noemi Esteras, Andrey Y Abramov
September 21, 2020
Open Access

Neuroinflammation and tau co-localize in vivo in progressive supranuclear palsy

Annals of Neurology
Maura MalpettiJames B Rowe
October 7, 2020
Review

Defective Mitophagy in Alzheimer's Disease

Ageing Research Reviews
Jangampalli Adi Pradeepkiran, P Hemachandra Reddy
October 20, 2020
Review
Open Access

The Role of Copper in Tau-Related Pathology in Alzheimer's Disease

Frontiers in Molecular Neuroscience
Klara ZubčićMaja Jazvinšćak Jembrek
October 5, 2020
Review

Tau at the interface between neurodegeneration and neuroinflammation

Genes and Immunity
Alessandro Didonna
September 15, 2020

Novel Amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity

Progress in Neurobiology
Christian GallreinJanine Kirstein
September 23, 2020

Retromer regulates the lysosomal clearance of MAPT/tau

Autophagy
Julian M CarosiTimothy J Sargeant
October 4, 2020
Open Access

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals

Alzheimer's Research & Therapy
Sylvain LehmannAlzheimer’s Disease Neuroimaging Initiative (ADNI)
September 29, 2020

Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway

Journal of Alzheimer's Disease : JAD
Natália Chermont Dos Santos MoreiraElza Tiemi Sakamoto-Hojo
October 13, 2020
Open Access

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease

Frontiers in Neurology
Annie G BryantRachel E Bennett

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tauopathy-biochemistry/cf253c17-da4c-4ee5-912f-deed325b7c13